mass spectrometry raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.
This page was last updated on 2025-11-10 and is reviewed periodically as new material appears.
Stability of AOD-9604 depends on storage conditions. Lyophilized powder is generally more stable than reconstituted solution. Recommended storage is typically at -20°C or lower, protected from light and moisture. Repeated freeze-thaw cycles can cause aggregation or degradation. In solution, the peptide may be susceptible to hydrolysis or oxidation, so aliquoting and cold storage are common practices. Researchers often add stabilizers such as mannitol or trehalose during lyophilization to improve shelf life.
Quality control for AOD-9604 involves verifying identity, purity, and concentration. Suppliers may provide a certificate of analysis listing HPLC purity and mass spectrometry data. Independent verification is advised because peptide products can vary in quality. Researchers should check for counterions, residual solvents, and microbial contamination. Proper documentation supports reproducibility and safety in laboratory studies. When sourcing, institutions often require third-party testing and detailed chain-of-custody records. These steps help ensure that experimental results are attributable to the peptide rather than impurities.
Analytical characterization of AOD-9604 typically employs reversed-phase high-performance liquid chromatography (RP-HPLC) to assess purity and identity. Mass spectrometry provides confirmation of molecular mass, while amino acid analysis can verify composition. These methods are standard for peptide research chemicals. Because the peptide lacks a distinct chromophore, detection often relies on ultraviolet absorbance at 214 nm or mass spectrometric response. Laboratories may also use capillary electrophoresis for separation. For example, size-exclusion chromatography can detect aggregates.
AOD-9604 is a synthetic peptide that corresponds to a short section of human growth hormone. It is commonly identified as hGH fragment 176-191 because its sequence matches residues at the C-terminal end of the hormone. The molecule contains sixteen amino acids and is made by solid-phase peptide synthesis. Researchers study it for metabolic effects rather than for the growth-promoting actions associated with full human growth hormone. Its small size distinguishes it from the complete 191-amino-acid hormone.
Several names appear in scientific and commercial settings. AOD9604 and AOD-9604 are development codes used interchangeably, while hGH fragment 176-191 describes the same region. The peptide includes a disulfide bond between two cysteine residues, which helps shape its three-dimensional structure. Different suppliers may provide acetate or other salt forms, and purity can vary. These differences matter because analytical tests and biological assays can respond to the specific form being studied.
| Property | Value | Notes |
|---|---|---|
| Appearance | White to off-white powder | Lyophilized form |
| Solubility | Soluble in water | Also soluble in aqueous buffers |
| Storage temperature | -20°C or below | Protect from light and moisture |
| Analytical method | RP-HPLC | Purity and identity assessment |
| Mass confirmation | Mass spectrometry | Verifies molecular mass |
AOD-9604 has been investigated primarily as a potential treatment for obesity and related metabolic conditions. Early laboratory work examined its effects on fat cells, and later studies moved into animal models and human clinical trials. Some trials reportedly reached Phase II, but the program did not lead to an approved medicine. Published summaries often note that weight-loss results were modest or inconsistent. The full trial data are not all publicly available in detail.
Regulatory treatment of AOD-9604 has varied. In sports anti-doping, the peptide became widely discussed during a 2013 investigation into an Australian professional sports club. Authorities at the time debated whether it fell under prohibitions on growth hormone and related substances. Later clarifications and updated lists have addressed the compound in different ways. Anyone seeking current status should consult the latest applicable rules, and commercial supply for human use is not authorized in major markets.
Research interest in AOD-9604 often focuses on whether it can influence lipid metabolism without the growth-promoting or glucose-related effects of full-length hGH. This question remains unresolved, and findings depend on model, dose, and measurement method. Some reviews treat the peptide as a historical obesity candidate rather than an active therapeutic. Others cite it in discussions of peptide fragments, metabolic signaling, and performance-enhancing substances. Clear conclusions are limited by the small number of rigorous, independent human studies.
Development of AOD-9604 began in the 1990s as scientists sought to isolate metabolic effects of growth hormone without its growth-promoting actions. Early laboratory work focused on fat cells and animal models. Several human trials followed, examining changes in body composition and fat mass. Results have been mixed, and the peptide has not progressed to widespread clinical approval. Interest continues in research settings, particularly regarding its mechanism and potential metabolic targets.
Regulatory status varies by country. In the United States, AOD-9604 is not approved as a prescription drug. It is sometimes sold as a research chemical or dietary supplement, though such marketing may fall outside legal frameworks. The World Anti-Doping Agency prohibits its use in sport. Researchers must obtain it through legitimate suppliers and follow institutional rules. Its legal classification continues to evolve as authorities increasingly assess peptide products more broadly.
AOD-9604 is listed as a prohibited substance in sport by the World Anti-Doping Agency. It falls under the peptide hormones, growth factors, related substances, and mimetics class on the prohibited list. Anti-doping organizations treat its presence in an athlete's sample as an adverse finding unless a therapeutic use exemption applies. The prohibition reflects concerns about performance enhancement in competitive settings and the difficulty of distinguishing exogenous peptide use from endogenous hormone fragments.
Detection of AOD-9604 in biological samples relies on analytical techniques capable of distinguishing a small synthetic peptide from related endogenous sequences. Liquid chromatography coupled with tandem mass spectrometry is commonly used for confirmatory analysis. Sample preparation may involve immunoaffinity enrichment or solid-phase extraction to concentrate the peptide. Because the molecule is small and may be present at low concentrations, assay sensitivity and specificity are ongoing analytical challenges. Laboratories also validate methods against reference materials when available.
Regulatory interest in AOD-9604 increased after high-profile anti-doping cases involving peptide products. In some cases, the substance was supplied under alternative names or in compounded preparations, complicating traceability. Sports tribunals and anti-doping panels have discussed whether the peptide was explicitly banned at the time of use, leading to clarifications by the World Anti-Doping Agency. For consumers and researchers, the legal status can vary by jurisdiction, and products marketed as research chemicals may lack independent quality verification.
The peptide is frequently described as a growth hormone fragment, although it is chemically distinct from full-length hGH. AOD-9604 contains 16 amino acids and includes two cysteine residues that can form an intramolecular disulfide bond. In solution, this structural feature can influence folding, aggregation, and stability. Published descriptions sometimes call it hGH 176-191 or AOD9604, with spacing and capitalization varying. Such naming differences can complicate literature searches, database entries, and product verification.
Researchers have studied the fragment in cell and animal models to understand its metabolic actions. Some experiments report effects on fat breakdown and fat storage pathways, but the underlying mechanism remains incompletely defined. AOD-9604 does not appear to stimulate the same broad growth hormone receptor signaling as full-length hGH. Whether its observed activities arise from direct receptor interactions or downstream metabolic changes is an open question. Results from different assays are not always consistent.
AOD-9604 is a synthetic peptide modeled on the C-terminal region of human growth hormone. It corresponds to residues 176-191 of the 191-amino-acid hGH sequence. The fragment is not the full hormone and lacks the receptor-binding region associated with growth and metabolic effects of hGH. Researchers developed it to isolate a specific portion of hGH for study. Its exact sequence and length are often stated in peptide catalogs and patents.
CGRP is released from both the trigeminal ganglion (TG) and the trigeminal nucleus caudalis (TNC) in response to trigeminal nerve activation. CGRP activates receptors on meningeal blood vessels, causing dilation and changes in blood flow. CGRP also activates specialized nerve endings on the dura mater (nociceptors) that transmit pain signals from the dura to the central nervous system. Increased neuronal activity in the trigeminal pain pathway reaches higher cortical pain regions via the brainstem, midbrain and thalamus. Stimulation of the trigeminal nerve may result in release of neuropeptides such as CGRP, vasodilation of cerebral and dural blood vessels, neurogenic inflammation, and the transmission of pain signals via nerves in the meninges. Cerebrospinal fluid may also play a role in migraine by transferring signals released from the brain to overlying pain-sensitive meningeal tissues, including dura mater.
== Preparation == Since its first description in 1953, ethylene carbonate has been commonly used as starting material for vinylene carbonate. In the first stage, monochlorethylene carbonate is produced in a UV-initiated photochlorination reaction with chlorine or sulfuryl chloride at 60-70 °C in bulk. In the second stage, monochlorethylenecarbonate undergoes dehydrochlorination with a base such as triethylamine.
Although leptin reduces appetite as a circulating signal, obese individuals generally exhibit a higher circulating concentration of leptin than normal weight individuals due to their higher percentage body fat. These people show resistance to leptin, similar to resistance of insulin in type 2 diabetes, with the elevated levels failing to control hunger and modulate their weight. A number of explanations have been proposed to explain this. An important contributor to leptin resistance is changes to leptin receptor signalling, particularly in the arcuate nucleus. However, deficiency of, or major changes to, the leptin receptor itself are not thought to be a major cause. Triglycerides crossing the blood brain barrier (BBB) can induce leptin and insulin resistance in the hypothalamus. Triglycerides can also impair leptin transport across the BBB. Studies on leptin cerebrospinal fluid (CSF) levels provide evidence for the reduction in leptin crossing the BBB and reaching obesity-relevant targets, such as the hypothalamus, in obese people. In humans it has been observed that the ratio of leptin in the CSF compared to the blood is lower in obese people than in people of a normal weight. The reason for this may be high levels of triglycerides affecting the transport of leptin across the BBB or due to the leptin transporter becoming saturated. Although deficits in the transfer of leptin from the plasma to the CSF is seen in obese people, they are still found to have 30% more leptin in their CSF than lean individuals. These higher CSF levels fail to prevent their obesity.
Sources: en.wikipedia.org
In December 2021, Newsom announced his intention to make California a "sanctuary" for abortion, which included possibly paying for procedures, travel, and lodging for out-of-state abortion seekers, if the procedure is banned in Republican-led states. In March 2022, he signed a bill requiring private health insurance plans in the state to fully cover abortion procedures by eliminating associated co-pays and deductibles and increasing insurance premiums. In February 2023, Newsom organized the Reproductive Freedom Alliance of state governors supportive of abortion and reproductive rights. After Walgreens announced in March 2023 that it would refuse to dispense abortion pills in the 21 states where it is illegal, Newsom tweeted, "California won't be doing business with @walgreens – or any company that cowers to the extremists and puts women's lives at risk, we're done." He also said that Walgreens was giving in to "right-wing bullies" and that he would determine how California could cut ties with it. He indicated that he wanted to cancel Walgreens's $54 million contract with the California state prison system. Walgreens also receives $1.5 billion for filling prescriptions for the 15 million people enrolled in the state's Medi-Cal program (California's version of Medicaid). Legal experts said that federal Medicaid laws do not allow health plans to disqualify providers for reasons other than fraud or contract violations, provisions that have prevented conservative states from blocking Medicaid spending to Planned Parenthood clinics.
Hong Kong culture is characterised as a hybrid of Eastern and Western culture. Traditional Chinese values emphasising family and education blend with Western ideals, including economic liberty and the rule of law. Although the vast majority of the population is ethnically Chinese, Hong Kong has developed a distinct identity. The territory diverged from the mainland through its long period of colonial administration and a different pace of economic, social, and cultural development. Mainstream culture was derived from immigrants originating from various parts of China; it was then influenced by British-style education, a separate political system, and the territory's rapid development during the late 20th century. Most migrants of that era fled poverty and war, reflected in the prevailing attitude toward wealth; Hongkongers would tend to link self-image and decision-making to material benefits. Residents' sense of local identity has increased post-handover: polling in December 2022 had 32% of respondents identifying as "Hongkongers", 34.1% identifying as "Hongkongers in China" 45.9% purporting a "Mixed Identity", 20.5% identifying as "Chinese" and 11.9% identifying as "Chinese in Hong Kong". Traditional Chinese family values, including family honour, filial piety, and a preference for sons, are prevalent. Nuclear families are the most common households, although multi-generational and extended families are not unusual. Spiritual concepts such as feng shui are observed; large-scale construction projects often hire consultants to ensure proper building positioning and layout.
==== 30th anniversary celebrations ==== Berlin planned a week-long arts festival from 4 to 10 November 2019 and a citywide music festival on 9 November to celebrate the 30th anniversary. On 4 November, outdoor exhibits opened at Alexanderplatz, the Brandenburg Gate, the East Side Gallery, Gethsemane Church, Kurfürstendamm, Schlossplatz, and the former Stasi headquarters in Lichtenberg.
Sources: en.wikipedia.org
Creating a CCP involves three steps: initiation, multiplication and mixture. The population then goes into the maintenance phase. A number of lines, generally 7-30, with interesting properties, such as yield or baking quality, are selected and all possible crosses of them are done. If many lines of different genetic background are used, a huge amount of genetic diversity will be present. Seeds from crosses are sown out and harvested separately for a growing season or two until enough seeds are available. All seeds are mixed in equal portions to produce the first CCP generation. The population is grown repeatedly and possibly changes due to natural selection. Each year seeds are saved after harvest, and used as seed for the next growing season. Plants that are successful under the prevailing growing conditions will give more seeds and contribute more to the next generation, compared to less successful plants. Disease will cull susceptible plants and the population will over time become resistant to the common diseases, but only if the initial population has resistance genes present.
=== 2009 Tongchuan, Shaanxi, China === In 2009, a Chinese cement company in Tongchuan, Shaanxi Province was demolishing an old, unused cement plant and did not follow standards for handling radioactive materials. This caused some caesium-137 from a measuring instrument to be included with eight truckloads of scrap metal on its way to a steel mill, where the radioactive caesium was melted down into the steel.
The first gene silencing approach to Alzheimer's disease is reported, with a drug called BIIB080 used on the microtubule-associated protein tau (MAPT) gene. Patients in a Phase 1 trial were found to have a greater than 50% reduction in levels of harmful tau protein after taking the drug. 26 April Astronomers present an image, for the first time viewed together, of the shadow of the black hole in the center of the Messier 87 galaxy, and its related high-energy jet. The first global assessment of glacier mass loss from satellite radar altimetry is published. It shows that glaciers lost 2,720 gigatonnes of ice, about 2% of their volume, between 2010 and 2020. 28 April – Progress in AI software: ChatGPT is shown to outperform human doctors in responding to online medical questions when measured on quality and empathy by "a team of licensed health care professionals", albeit the chatbot may have previously been trained with these reddit question and answers threads.
Hydra vulgaris, (previously Hydra magnipapillata), a model hydrozoan (2010) Nematostella vectensis, a model sea anemone (starlet sea anemone) (2007) Aiptasia pallida, a sea anemone (2015) Renilla muelleri, an octocoral (2017, 2019) Stylophora pistillata, a coral (2017) Aurelia aurita, moon jellyfish (2019) Clytia hemisphaerica, Hydrozoan jellyfish (2019) Myxobolus honghuensis (2022) Nemopilema nomurai, Nomura jellyfish (2019) Rhopilema esculentum, Flame jellyfish (2020) Cassiopea xamachana (Scyphozoa) (2019) Alatina alata (Cubozoa) (2019) Calvadosia cruxmelitensis (Staurozoa) (2019) Dendronephthya gigantea, an octocoral (2019) Acropora acuminata (2020) Acropora awi (2020) Acropora cytherea, Table coral (2020) Acropora digitifera, a coral (2011) Acropora echinata (2020) Acropora florida, branching staghorn coral(2020) Acropora gemmifera (2021) Acropora hyacinthus, Brush coral (2020) Acropora intermedia, Noble Staghorn Coral (2020) Acropora microphthalma (2020) Acropora muricata, Staghorn coral (2020) Acropora nasta, branching staghorn coral (2020) Acropora pulchra (2025) Acropora selago, Green Selago Acropora (2020) Acropora tenuis, Purple Tipped Acropora (2020) Acropora yongei ,Yonge's staghorn coral (2020) Corallium rubrum, Precious coral (2024) Astreopora myriophthalma, Porous star coral (2020) Lophelia pertusa, Deepwater White Coral (2023) Montipora cactus (2020) Montipora capitata, Rice coral (2022) Montipora efflorescens, Velvet coral (2020) Orbicella faveolata, mountainous star coral (2016) Paragorgia papillata, Bubble-gum coral (2025) Pocillopora acuta, Hosoeda Hanayasai coral (2022) Pocillopora damicornis, cauliflower coral (2018) Pocillopora meandrina, Cauliflower coral (2022) Porites astreoides, Mustard hill coral (2022) Porites compressa, Finger coral (2022)
Sources: en.wikipedia.org
Reversed-phase HPLC is used to assess purity, and mass spectrometry confirms molecular mass. Amino acid analysis can verify composition. These methods are standard for peptide characterization.
Lyophilized powder should be stored at -20°C or lower, protected from light and moisture. Reconstituted solutions are less stable and should be aliquoted to avoid freeze-thaw cycles. Always follow supplier instructions.
Variability in purity, counterion content, and residual solvents is possible. Independent testing and certificates of analysis help verify quality. Microbial contamination can occur if handling is not sterile.
AOD-9604 is a synthetic peptide fragment of human growth hormone. It corresponds to the C-terminal region known as hGH 176-191 and is studied for metabolic effects. It is not an approved therapeutic drug.